Sanofi (HAM:SNW) General and Admin. Expense: €9,543 Mil (TTM As of Dec. 2025)


HAM:SNW Sanofi SA HAM:SNW
88 GF Score
Price €72.91
GF Value €106.86
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Sanofi General and Admin. Expense?

Sanofi HAM:SNW -3.14% 88 General and Admin. Expense is €9,543 Mil as of Dec. 2025. GuruFocus rates HAM:SNW with a GF Score™ of 88/100 and a GF Value™ of €106.86 (Possible Value Trap). The stock has 2 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Sanofi's General and Admin. Expense for the six months ended in Dec. 2025 was €5,037 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 was €9,543 Mil.

Sanofi General and Admin. Expense Related Terms

Sanofi General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Sanofi's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sanofi General and Admin. Expense Chart

Sanofi Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 8,933.00 9,183.00 9,543.00

Sanofi Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 4,303.00 4,880.00 4,506.00 5,037.00
HAM:SNW
88GF Score
Sanofi SA HAM:SNW
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sanofi General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €9,543 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of €9,543 Mil mean?
Sanofi (HAM:SNW) has a General and Admin. Expense of €9,543 Mil as of Dec. 2025. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Sanofi and its competitors.
Is Sanofi's General and Admin. Expense too high?
Sanofi's current General and Admin. Expense is €9,543 Mil. Overall, Sanofi has a GF Score™ of 88/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sanofi's General and Admin. Expense compare to LLY and JNJ?
Sanofi's General and Admin. Expense of €9,543 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Drug Manufacturers company?
A good General and Admin. Expense depends on the Drug Manufacturers industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Sanofi and its competitors. Sanofi's current General and Admin. Expense is €9,543 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanofi stock overvalued right now?
Based on GuruFocus' analysis, Sanofi (HAM:SNW) is currently considered Possible Value Trap. The stock's GF Value™ is €106.86, compared to a current price of €72.91 — trading 31.8% below its estimated fair value. The current General and Admin. Expense is €9,543 Mil. Sanofi's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Sanofi (HAM:SNW), the current General and Admin. Expense is €9,543 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sanofi (HAM:SNW) Overvalued in 2026?

Based on GuruFocus' analysis, Sanofi stock appears to be undervalued. The current stock price of €72.91 is trading 31.8% below its estimated GF Value™ of €106.86. GuruFocus considers Sanofi to be Possible Value Trap.

Key valuation signals for HAM:SNW:

  • General and Admin. Expense: €9,543 Mil
  • GF Value™: €106.86 vs. price of €72.91 (31.8% below fair value)
  • GF Score™: 88/100 with 2 warning signs

No single metric tells the full story. See the HAM:SNW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sanofi Business Description

Address 46, Avenue de la Great Army, Paris, FRA, 75017
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
88GF Score

Get the complete analysis for HAM:SNW

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€72.91
Price
€106.86
GF Value